Contrast-induced nephropathy: Definition, epidemiology, and patients at risk

Kidney International

Volumn 69, Issue SUPPL. 100, 2006, Pages

  Mehran, R ^a,c   Nikolsky, E ^b  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Contrast induced nephropathy; Contrast media; Epidemiology

Indexed keywords

ANTIBIOTIC AGENT; CONTRAST MEDIUM; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; NONSTEROID ANTIINFLAMMATORY AGENT;

CARDIOVASCULAR DISEASE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIAGNOSTIC IMAGING; DRUG EXPOSURE; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY DISEASE; NEPHROTOXICITY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; AGE; AGED; ANEMIA; BLOOD; CHEMICALLY INDUCED DISORDER; DIABETIC NEPHROPATHY; OSMOLARITY;

AGE FACTORS; AGED; ANEMIA; CONTRAST MEDIA; CREATININE; DIABETIC NEPHROPATHIES; HUMANS; INCIDENCE; KIDNEY DISEASES; OSMOLAR CONCENTRATION; RISK FACTORS;

EID: 33746926391     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000368     Document Type: Article

References (38)

1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936.
2. Stevens MA, McCullough PA, Tobin KJ et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study: Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999; 33: 403-411.
3. Guitterez NV, Diaz A, Timmis GC et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol 2002; 15: 349-354.
4. McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003; 4(Suppl 5): S3-S9.
5. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the US Food and Drug Administration. Radiology 1997; 203: 605-610.
6. Parfrey PS, Griffiths SM, Barrett BJ et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-149.
7. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990; 150: 1237-1242.
8. Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.
9. McCullough PA, Wolyn R, Rocher LL et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375.
10. Marenzi G, Lauri G, Assanelli E et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780-1785.
11. Gruberg L, Mehran R, Dangas G et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001; 52: 409-416.
12. Hall KA, Wong RW, Hunter GC et al. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 1992; 53: 317-320.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461-470.
15. Ahuja TS, Niaz N, Agraharkar M. Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 2000; 54: 11-14.
16. Nikolsky E, Mehran R, Turcot D et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004; 94: 300-305.
17. Kurnik BR, Allgren RL, Genter FC et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998; 31: 674-680.
18. Lautin EM, Freeman NJ, Schoenfeld AH et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. Am J Roentgenol 1991; 157: 49-58.
19. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989; 36: 730-740.
20. Gussenhoven MJ, Ravensbergen J, van Bockel JH et al. Renal dysfunction after angiography; a risk factor analysis in patients with peripheral vascular disease. J Cardiovasc Surg (Torino) 1991; 32: 81-86.
21. Kini AS, Mitre CA, Kim M et al. A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam. Catheter Cardiovasc Interv 2002; 55: 169-173.
22. Albert SG, Shapiro MJ, Brown WW et al. Analysis of radiocontrast-induced nephropathy by dual-labeled radionuclide clearance. Invest Radiol 1994; 29: 618-623.
23. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002; 89: 356-358.
24. Rosovsky MA, Rusinek H, Berenstein A et al. High-dose administration of nonionic contrast media: a retrospective review. Radiology 1996; 200: 119-122.
25. Kahn JK, Rutherford BD, McConahay DR et al. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J 1990; 120: 533-536.
26. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990; 89: 615-620.
27. Vlietstra RE, Nunn CM, Narvarte J, Browne KF. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J 1996; 132: 1049-1050.
28. Nikolsky E, Mehran R, Lasic Z et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005; 67: 706-713.
29. Pollock DM, Polakowski JS, Wegner CD, Opgenorth TJ. Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy. Ren Fail 1997; 19: 753-761.
30. Oymak O. Contrast media induced irreversible acute renal failure in a patient treated with intraperitoneal cisplatin. Clin Nephrol 1995; 44: 135-136.
31. Raynal-Raschilas N, Deray G, Bagnis C, Jacobs C. Severe acute renal failure after administration of contrast media in a patient treated with cisplatin. Nephrol Dial Transplant 1996; 11: 2522-2523.
32. Dangas G, Iakovou I, Nikolsky E et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95: 13-19.
33. Katholi RE, Taylor GJ, Woods WT et al. Nephrotoxicity of nonionic low-osmolarity versus ionic high-osmolarity contrast media: a prospective double-blind randomized comparison in human beings. Radiology 1993; 186: 183-187.
34. Harris KG, Smith TP, Cragg AH, Lemke JH. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. Radiology 1991; 179: 849-852.
35. Schwab SJ, Hlatky MA, Pieper KS et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989; 320: 149-153.
36. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolarity iodinated contrast media. Radiology 1993; 188: 171-178.
37. Aspelin P, Aubry P, Fransson SG et al. Nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-499.
38. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399.